6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
New Insights and Advances in Addiction Research
The Addiction Research Center Stock, shortened ARCI, could be a standardized survey for surveying subjective effects of psychoactive drugs that was created within the early 1960s at the National Organized of Mental Health Compulsion Inquire about center. This self-report stock was created from the utilize of "sentence completion" and other affiliation strategies on male subjects under drug and no-drug conditions. In expansion to illustrated "drug-sensitive" questions, the ultimate frame of the stock too contains things which were thought to portray to a few degree schizoid and "psychopathic" characteristics. Introductory utilize demonstrated that the stock was successful in separating different subjective impacts of drugs and in separating a few likenesses and contrasts of actually happening and tentatively actuated behavioral variations from the norm.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States